Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 11 October 2019. Database contains 223 unique substances/entries.
Filter the list
Latest update:
Date of intention:
Date of RMOA conclusion:

 
207-995-2
504-60-9
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
15/08/2017
Details
201-071-2
77-94-1
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
22/01/2019
Details
-
5436-43-1
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
Other
23/08/2019
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
12/09/2018
Details
231-150-7
7440-41-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
19/12/2016
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
610-589-1
50926-11-9
Netherlands
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
13/10/2017
Details
231-106-7
7439-97-6
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
15/10/2018
Details
215-181-3
1310-58-3
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
215-185-5
1310-73-2
Sweden
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
Other
08/04/2015
Details
260-830-6
57583-54-7
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
256-032-2
42978-66-5
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
230-528-9
7173-62-8
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
431-890-2
-
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/03/2016
Details
240-260-4
16096-31-4
Denmark
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
219-799-4
2536-05-2
Denmark
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
201-841-8
88-58-4
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
202-039-0
91-08-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
209-544-5
584-84-9
Denmark
Aggregated tonnage
Carcinogenic
Exposure
Mutagenic
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
292-562-0
90640-43-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
This substance is identified by SDA Substance Name: N-C12-C18 alkyl propylene diamine and SDA Reporting Number: 16-032-00.
268-957-9
68155-37-3
Sweden
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
200-539-3
62-53-3
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
229-176-9
6422-86-2
France
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
25/01/2019
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77377.
269-047-4
68186-85-6
Netherlands
Other environmental toxicity
Other human toxicity
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
231-847-6
7758-98-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
215-271-2
1317-40-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/10/2015
Details
222-583-2
3542-36-7
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
629-757-0
1224966-15-7
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
200-579-1
64-18-6
Bulgaria
Bioaccumulation
Endocrine disruption
Other human toxicity
Persistence
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
247-722-4
26471-62-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
232-089-9
7785-87-7
Denmark
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
231-106-7
7439-97-6
Sweden
Other human toxicity
STOT RE
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
200-659-6
67-56-1
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
08/07/2016
Details
247-714-0
26447-40-5
Denmark
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
629-719-3
1219010-04-4
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
240-841-2
16812-54-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
12/05/2017
Details
227-534-9
5873-54-1
Denmark
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
272-486-4
68855-45-8
Sweden
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
28/11/2018
Details
272-233-8
68784-25-8
Sweden
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
28/11/2018
Details
272-234-3
68784-26-9
Sweden
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
28/11/2018
Details
202-051-6
91-22-5
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/07/2015
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details

Export search results to:

Categories Display


Route: .live1